中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
11期
42-43,44
,共3页
刘旺%吴格怡%骆国泉%郑美乔
劉旺%吳格怡%駱國泉%鄭美喬
류왕%오격이%락국천%정미교
喘可治注射液%胸腺肽%支气管哮喘%IgE%IL-4
喘可治註射液%胸腺肽%支氣管哮喘%IgE%IL-4
천가치주사액%흉선태%지기관효천%IgE%IL-4
Chuankezhe injection%Thymic peptide%Asthma%IgE%IL-4
目的:观察喘可治注射液联合胸腺五肽治疗对支气管哮喘患者IgE、IL-4等免疫功能的影响。方法:将86例确诊为支气管哮喘患者随机分为治疗组及对照组,对照组给予常规治疗,治疗组在对照组的基础上加用喘可治注射液联合胸腺五肽治疗,治疗2周后,抽取静脉血观察患者血液IgE、IL-4改变,对比两组差异。结果:喘可治注射液联合胸腺五肽治疗组IgE、IL-4均较对照组改善,差异有统计学意义(P<0.05)。结论:喘可治注射液联合胸腺肽对支气管哮喘患者有较好的治疗作用,可改善IgE、IL-4而达到很好的平喘及免疫调节作用,值得临床推荐。
目的:觀察喘可治註射液聯閤胸腺五肽治療對支氣管哮喘患者IgE、IL-4等免疫功能的影響。方法:將86例確診為支氣管哮喘患者隨機分為治療組及對照組,對照組給予常規治療,治療組在對照組的基礎上加用喘可治註射液聯閤胸腺五肽治療,治療2週後,抽取靜脈血觀察患者血液IgE、IL-4改變,對比兩組差異。結果:喘可治註射液聯閤胸腺五肽治療組IgE、IL-4均較對照組改善,差異有統計學意義(P<0.05)。結論:喘可治註射液聯閤胸腺肽對支氣管哮喘患者有較好的治療作用,可改善IgE、IL-4而達到很好的平喘及免疫調節作用,值得臨床推薦。
목적:관찰천가치주사액연합흉선오태치료대지기관효천환자IgE、IL-4등면역공능적영향。방법:장86례학진위지기관효천환자수궤분위치료조급대조조,대조조급여상규치료,치료조재대조조적기출상가용천가치주사액연합흉선오태치료,치료2주후,추취정맥혈관찰환자혈액IgE、IL-4개변,대비량조차이。결과:천가치주사액연합흉선오태치료조IgE、IL-4균교대조조개선,차이유통계학의의(P<0.05)。결론:천가치주사액연합흉선태대지기관효천환자유교호적치료작용,가개선IgE、IL-4이체도흔호적평천급면역조절작용,치득림상추천。
Objective:To observe impact of Chuankezhe injection combined with thymic peptide on IgE、IL-4 in patients with bronchial asthma.Method:86 patients with diagnosis of bronchial asthma were randomly divided into treatment group and the blank control group,2 weeks after treatment,patients with venous blood was drawn to observe blood IgE,IL-4 change,the differences between the two groups were compared.Result:The treatment group for Chuankezhe injection combined with thymic peptide treatment IgE,IL-4 improved than control group,the difference was statistically significant(P<0.05).Conclusion:Chuankezhe injection in combination with thymic peptide treatment has good therapeutic effect in patients with bronchial asthma,can improve the IgE,IL-4 and achieves very good smooth wheezing and immunomodulatory effect,worth clinical recommendations.